Medtronic Reportedly in Merger Talks with Covidien
Medical-device maker Medtronic (NYSE: MDT) is reportedly in advanced merger talks with rival Covidien (NYSE: COV), according to sources, as reported by the Wall Street Journal. The deal, which is said to be valued at $45-$50 billion, could be announced on Monday.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.